Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo Transplant
Clinical trial NCT03459170 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03459170
- Sponsor
- Bellicum Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-01
- Primary completion
- 2022-09-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.